When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Genprex, Inc. (GNPX) has been on an outstanding two-day run since it announced that the FDA has granted Fast Track Designation for its Oncoprex immunogene therapy in combination with AstraZeneca's (AZN) Tagrisso for certain non-small cell lung cancer patients. The stock has risen from $0.36 to $1.90 during that time on nearly 100 million shares traded, adding $30 million to its market cap. While the fast track news is an excellent development for the company, investors must remain cognizant of the fact that this is still a very early stage drug.